isoflurane has been researched along with Hepatorenal Syndrome in 1 studies
Isoflurane: A stable, non-explosive inhalation anesthetic, relatively free from significant side effects.
Hepatorenal Syndrome: Functional KIDNEY FAILURE in patients with liver disease, usually LIVER CIRRHOSIS or portal hypertension (HYPERTENSION, PORTAL), and in the absence of intrinsic renal disease or kidney abnormality. It is characterized by intense renal vasculature constriction, reduced renal blood flow, OLIGURIA, and sodium retention.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukuda, H | 1 |
| Kawamoto, M | 1 |
| Yuge, O | 1 |
| Fujii, K | 1 |
1 trial available for isoflurane and Hepatorenal Syndrome
| Article | Year |
|---|---|
A comparison of the effects of prolonged (>10 hour) low-flow sevoflurane, high-flow sevoflurane, and low-flow isoflurane anaesthesia on hepatorenal function in orthopaedic patients.
Topics: Adult; Anesthesia, Inhalation; Anesthetics, Inhalation; Biomarkers; Chromatography, Gas; Ethers; Fem | 2004 |